Peripheral T-cell lymphoma, NEC, intrathoracic lymph nodes is a subtype of non-Hodgkin lymphoma characterized by the proliferation of malignant T-cells in the lymphatic system, specifically affecting the lymph nodes located in the thoracic cavity. This condition is clinically significant due to its aggressive nature and potential for systemic involvement. Accurate coding with ICD-10 Code C84.42 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this malignancy.
ICD-10 Code C84.42 represents Peripheral T-cell lymphoma, NEC, intrathoracic lymph nodes, a rare and aggressive form of lymphoma that arises from T-lymphocytes. This code is used when documenting cases where the lymphoma is specifically localized to the intrathoracic lymph nodes, allowing for precise clinical documentation and billing. It is crucial for healthcare providers to use this code when diagnosing patients with this condition to ensure appropriate treatment and reimbursement.
Peripheral T-cell lymphoma, NEC, intrathoracic lymph nodes is a hematological malignancy that arises from the neoplastic transformation of T-cells. The condition can progress rapidly, leading to significant morbidity and mortality if not addressed promptly. Medical attention is required for diagnosis and management, including chemotherapy and possibly stem cell transplantation.
In clinical workflows, ICD-10 Code C84.42 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, facilitating accurate communication among healthcare providers and ensuring comprehensive patient management.
ICD-10 Code C84.42 serves as a critical link between subjective patient reports and objective clinical findings, establishing a formal diagnosis. This code supports continuity of care, aids in billing processes, and meets EHR documentation standards, ensuring that all aspects of patient management are appropriately captured.
Management of Peripheral T-cell lymphoma, NEC, intrathoracic lymph nodes often necessitates hospitalization due to the aggressive nature of the disease. Treatment typically involves chemotherapy and may require supportive care.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.42 is crucial for accurate billing in hospital, emergency room, and infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 36415 | Collection of venous blood by venipuncture. |
| 77014 | Radiologic guidance for needle placement. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C84.42 for Peripheral T-cell lymphoma, NEC, intrathoracic lympth nodes
What are the common symptoms of Peripheral T-cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and respiratory issues if the lymphoma affects intrathoracic lymph nodes.
How is Peripheral T-cell lymphoma diagnosed?
Diagnosis typically involves imaging studies, such as CT scans, and biopsy of affected lymph nodes to confirm the presence of malignant T-cells. Laboratory tests may also be conducted to assess overall health.
What treatment options are available for Peripheral T-cell lymphoma?
Treatment often includes chemotherapy, radiation therapy, and in some cases, stem cell transplantation. Supportive care is also crucial to manage symptoms and side effects.
Is Peripheral T-cell lymphoma contagious?
No, Peripheral T-cell lymphoma is not contagious. It is a malignancy arising from T-cells and does not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes